✦ LIBER ✦

Preclinical studies predicting low clinical toxicity of the anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) nimotuzumab

✍ Scribed by Angel Casacó; Nuris Ledón; Normando Iznaga-Escobar; Maria Elena Arteaga; Tania Crombet

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergistic effects of chemotherapy and

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Phase II study of nimotuzumab, a humaniz

✍ Dirk Strumberg, Beate Schultheis, M. E. Scheulen, R. A. Hilger, J. Krauss, N. Ma 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 144 KB

1247 Phase I study of nimotuzumab, a hum

✍ N. Boku; K. Yamazaki; A. Fukutomi; T. Takahashi; N. Yamamoto; M. Miyazaki; T. Sa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

732 POSTER Phase I clinical study of the

✍ J. Soriano; N. Batista; M. Lima; R. Rodríguez; M.V. López; A. Montenegro; M. Ram 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 83 KB

6143 POSTER Study 20050203/PRIME – Effec

✍ Siena, S.; Douillard, J.Y.; Cassidy, J.; Tabernero, J.; Burkes, R.; Barugel, M.E 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Results of a phase I trial of the humani

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB